dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Arnaldos-Pérez, Cristina |
dc.contributor.author | Vilaseca Jolonch, Andreu |
dc.contributor.author | Naranjo, Laura |
dc.contributor.author | Sabater, Lidia |
dc.contributor.author | Dalmau, Josep |
dc.contributor.author | Ruiz-García, Raquel |
dc.date.accessioned | 2023-07-04T06:43:35Z |
dc.date.available | 2023-07-04T06:43:35Z |
dc.date.issued | 2023-05-03 |
dc.identifier.citation | Arnaldos-Pérez C, Vilaseca A, Naranjo L, Sabater L, Dalmau J, Ruiz-García R, et al. Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies. Front Immunol. 2023 May 3;14:2219. |
dc.identifier.issn | 1664-3224 |
dc.identifier.uri | https://hdl.handle.net/11351/9951 |
dc.description | Assaig basat en cèl·lules; Síndromes neurològiques paraneoplàstiques; Càncer de pulmó de cèl·lules petites |
dc.description.sponsorship | This study was funded by Instituto de Salud Carlos III - Subdirección General de Evaluación y Formento de la Investigación Sanitaria and co-funded by European Union, FIS (PI21/00255, RR-G). |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Immunology;14 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Diagnòstic |
dc.subject | Algorismes |
dc.subject | Símptomes |
dc.subject.mesh | Paraneoplastic Syndromes |
dc.subject.mesh | Lung Neoplasms |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Algorithms |
dc.title | Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fimmu.2023.1173484 |
dc.subject.decs | síndromes paraneoplásicos |
dc.subject.decs | neoplasias pulmonares |
dc.subject.decs | /diagnóstico |
dc.subject.decs | algoritmos |
dc.relation.publishversion | https://doi.org/10.3389/fimmu.2023.1173484 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Arnaldos-Pérez C, Naranjo L] Immunology Department, Centre Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Spain. [Vilaseca A] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Sabater L] Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. [Dalmau J] Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States. [Ruiz-García R] Immunology Department, Centre Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Spain. Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain |
dc.identifier.pmid | 37207233 |
dc.identifier.wos | 000987595300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |